Lucid Diagnostics Inc.
LUCD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001799011
No open-market purchases or sales by Lucid Diagnostics Inc. insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $65.7M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Lucid Diagnostics Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +2 vs. Q3 2023
- Shares held
- 1.75M
- −93.9K (−5.1%) vs. Q3 2023
- Total value
- $2.46M
- +$309.8K (+14.4%) vs. Q3 2023
- New holders
- 3
- 5 more added
- Sold out
- 1
- 8 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LUCD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 115 | $65.7M |
| Q1 2026 | 103 | $41.0M |
| Q4 2025 | 89 | $35.0M |
| Q3 2025 | 86 | $35.5M |
| Q2 2025 | 72 | $21.7M |
| Q1 2025 | 49 | $14.0M |
| Q4 2024 | 33 | $2.70M |
| Q3 2024 | 29 | $2.00M |
| Q2 2024 | 34 | $1.64M |
| Q1 2024 | 30 | $1.69M |
| Q4 2023 | 25 | $2.46M |
| Q3 2023 | 24 | $2.24M |
| Q2 2023 | 18 | $2.59M |
| Q1 2023 | 19 | $2.49M |
| Q4 2022 | 23 | $2.60M |
| Q3 2022 | 23 | $3.52M |
| Q2 2022 | 31 | $5.55M |
| Q1 2022 | 32 | $9.09M |
| Q4 2021 | 35 | $17.8M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Lucid Diagnostics Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hantz Financial Services, Inc. | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 198 | $0 | 0.00% | +198 | New |
| Bank of America Corp | 14 | $20 | 0.00% | −160−92.0% | Reduced |
| JPMorgan Chase & Co | 47 | $66 | 0.00% | +34+261.5% | Added |
| Qube Research & Technologies Ltd | 104 | $147 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 200 | $282 | 0.00% | 00.0% | Unchanged |
| Advisory Services Network, LLC | 765 | $1.08K | 0.00% | +765 | New |
| Tower Research Capital LLC (TRC) | 1,015 | $1.43K | 0.00% | −1,976−66.1% | Reduced |
| Advisor Group Holdings, Inc. | 2,000 | $2.82K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,708 | $8.05K | 0.00% | +192+3.5% | Added |
| Byrne Asset Management LLC | 6,610 | $9.52K | 0.01% | −600−8.3% | Reduced |
| Wells Fargo & Company | 9,081 | $12.8K | 0.00% | +40.0% | Added |
| State Street Corp | 10,521 | $14.8K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 12,345 | $17.4K | 0.00% | −4,977−28.7% | Reduced |
| Virtu Financial LLC | 20,836 | $29.0K | 0.00% | +20,836 | New |
| BlackRock Inc. | 23,453 | $33.1K | 0.00% | −288−1.2% | Reduced |
| Citadel Advisors LLC | 29,639 | $41.8K | 0.00% | −6,736−18.5% | Reduced |
| LPL Financial LLC | 32,630 | $46.0K | 0.00% | +4,230+14.9% | Added |
| Geneos Wealth Management Inc. | 33,850 | $47.7K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 36,166 | $51.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 131,871 | $186.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 135,000 | $190.3K | 0.00% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 149,698 | $211.1K | 0.02% | −8,437−5.3% | Reduced |
| Vanguard Group Inc | 332,391 | $468.7K | 0.00% | +6,825+2.1% | Added |
| Luminus Management LLC | 773,246 | $1.09M | 0.30% | −101,854−11.6% | Reduced |
| CWM, LLC | 0 | $0 | 0.00% | −1,920−100.0% | Sold out |
| Ayrton Capital LLC | – | – | – | – | Not filed |